Top story

RFK Jr. to Allow Broad Use of Unapproved Peptide Injections

In a unilateral declaration by the health secretary, several injections promoted by online influencers will become widely available. The F.D.A. had advised against the move.

Read full story

FDA Accepts Shionogi’s Ensitrelvir NDA for Review as the First Oral Therapy for the Prevention of COVID-19 Following Exposure

Drugs.com - New Drug Applications

Wed, 03 Sep 2025

??? ????? ??? ??????? ??. ??? ??????????

Pharmacy and Poisons Board

By Public Relations - September 2, 2025

FDA Approves Updated Covid Vaccines With New Restrictions

The New York Times - Drugs & Pharmaceuticals

By Christina Jewett and Jacey Fortin - Wed, 27 Aug 2025

FDA Removes Risk Evaluation and Mitigation Strategy (REMS) Program for the Antipsychotic Drug Clozapine

Drugs.com - FDA MedWatch Drug Alerts

Wed, 27 Aug 2025

Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling

Drugs.com - FDA MedWatch Drug Alerts

Wed, 27 Aug 2025

Pfizer and BioNTech’s Comirnaty Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Drugs.com - New Drug Approvals

Wed, 27 Aug 2025

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2

Drugs.com - New Drug Approvals

Wed, 27 Aug 2025

Travere Therapeutics Announces U.S. FDA Approves REMS Modification for Filspari (sparsentan) in IgA Nephropathy

Drugs.com - New Drug Approvals

Wed, 27 Aug 2025

Novavax's Nuvaxovid 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Drugs.com - New Drug Approvals

Wed, 27 Aug 2025